https://www.selleckchem.com/pr....oducts/AZD1152-HQPA.
2 ml/s (range 13.9-41 ml/s), insignificant PVR and resolution of renal failure. Patients with pdet@Qmax 20 cm H O ( = 3, mean 18.3 cm H O) did equally well as compared to those with pdet@Qmax 20 cm H O ( = 4, mean 93 cm H O). None of the patients developed any complications on follow-up. Clinical assessment supported with VUDS correlation holds a key in identifying patients with PBNO. BNR is a safe and effective treatment of PBNO in women who fail or are not candidates for conservative treatment. Clinical assessment support
Like
Comment
Share
